CME Certificates will be issued digitally after Speaker Evaluations and Overall Surveys are completed. Surveys are accessible after logging in with the email address you submitted during registration. Surveys will be available online starting the day of the symposium. You must complete the process by August 12, 2024 in order to receive your certificate. Certificates will be available online until December 31st and are printable directly from the website.


The AAFP has reviewed 30th Annual San Diego Heart Failure Symposium and deemed it acceptable for up to 10.75 Live AAFP Prescribed credits. Term of Approval is from 07/19/2024 to 07/20/2024. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.


To keep pace with the rapid growth in our understanding of heart failure and, most importantly, to better treat patients with this disease, the 30th Annual San Diego Heart Failure Symposium will provide a comprehensive overview of emerging concepts of heart failure management and new approaches to therapy. The series of didactic presentations, case discussions and Q & A sessions are designed to efficiently deliver new information that will help provide better care to patients and offer expert advice of how to implement new advances into clinical practice.

This year's Symposium will present sessions on Modifying Lifestyle and Treating Risk Factors, Advances in Patient Management, Cardiomyopathy: Understanding Causes and Novel Therapies, Management of Patients with Heart Failure with Reduced Ejection Fraction, Advances in Treating Patients with Cardiogenic Shock and Novel and Advanced Therapies for Heart Failure. The lectures in these sessions will provide a comprehensive overview of new drugs, devices and strategies for treating patients with heart failure and will describe practical approaches for implementation. Highlights of the Symposium will be the 10th Annual Stanley Lloyd, M.D. Lecture on Heart Failure and Pregnancy and Featured Talks on The Cardiometabolic Syndrome: A New Framework for Understanding Heart Failure, Advances in Understanding and Treating Patients with HFpEF, Diagnosing and Treating Amyloidosis, Genetic Causes of Cardiomyopathy and Advances in Heart Transplantation-What Does the Future Hold? To celebrate the 30th Anniversary of the Symposium, the program director will present the Founders Lecture on The Future of Heart Failure.

For this year’s Symposium the program director has recruited a world-renowned faculty representing multiple disciplines as well as patient advocates who will provide an important perspective on the goals of therapy. As in the past, the Symposium will be presented in hybrid format. We encourage providers to attend the live presentations at the beautiful Hilton La Jolla Torrey Pines where they can interact with their colleagues, speakers and industry representatives over the two-day Symposium. For those who can’t attend, on-line streaming of all sessions will be available. In addition, the Symposium will be available on-line for several weeks so that you will be able to return to lectures of interest or catch up on those that you missed.


At the conclusion of this activity, participants should be able to:

  1. Summarize current and emerging treatments available for preventing and treating heart failure and provide information to help in the selection of the most effective choices in individual patients.
  2. Review strategies for implementing medical and device therapies that will lead to improved outcomes in heart failure patients.
  3. Define how specific populations including minorities, women and the elderly respond to various approaches to treating risk factors and heart failure

The target audience for this activity includes cardiologists, internists, primary care physicians, nurses and allied healthcare professionals.


Heart failure (HF) is common, currently affecting well over million Americans. Moreover, prevalence is increasing in both developed and developing countries around the world. In the U.S. alone, an estimated 670,000 new cases of heart failure are diagnosed each year. Perhaps of greatest importance is that heart failure is a major cause of morbidity and mortality. Within 8 years of diagnosis, 80% of men and 70% of women less than 65 years of age with new onset heart failure will die. Overall, HF is the number one cause of hospitalizations of the elderly in the U.S.

Knowledge about HF is accumulating rapidly. The Symposium is designed to help clinicians synthesize new information about heart failure and integrate it into effective strategies of care of their patients. The Symposium will provide a comprehensive overview of diagnostic approaches, current evidence-based therapies and treatment strategies as well as emerging approaches for treatment.